4//SEC Filing
Herchuk Jannie Prestridge 4
Accession 0001641172-25-013806
CIK 0000926617other
Filed
Jun 4, 8:00 PM ET
Accepted
Jun 5, 4:06 PM ET
Size
7.8 KB
Accession
0001641172-25-013806
Insider Transaction Report
Form 4
Herchuk Jannie Prestridge
Director
Transactions
- Exercise/Conversion
Common Stock
2025-06-04+8,437→ 82,502 total - Exercise/Conversion
Restricted Stock Units
2025-06-04−8,437→ 0 total→ Common Stock (8,437 underlying)
Footnotes (3)
- [F1]Represents the conversion upon vesting of restricted stock units (RSUs) into common stock. On August 22, 2024, the reporting person was granted 33,750 RSUs, 8,437 of which vested on June 4, 2025. Such RSUs were previously reported in Table II on a Form 4 filed with the SEC on August 26, 2024.
- [F2]Each restricted stock unit is the economic equivalent of one share of Aspira Women's Health Inc. Stock.
- [F3]On August 22, 2024, the reporting person was granted 33,750 RSUs, 8,437 of which vested on June 4, 2025. The common stock into which such vested RSUs converted on June 4, 2025 is reported in Table I on this Form 4.
Documents
Issuer
Aspira Women's Health Inc.
CIK 0000926617
Entity typeother
Related Parties
1- filerCIK 0001973204
Filing Metadata
- Form type
- 4
- Filed
- Jun 4, 8:00 PM ET
- Accepted
- Jun 5, 4:06 PM ET
- Size
- 7.8 KB